ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
Lambe, Spencer, Thomas, Gilbert and colleagues report on the detailed immune profile of rhesus macaques and ferrets vaccinated against SARS-CoV-2 under high dose challenge. Their findings indicate that the ChAdOx1 nCoV-19 (AZD1222) the vaccine induces immune responses and reduces disease symptoms in...
Guardado en:
Ejemplares similares
-
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
por: Sue Ann Costa Clemens, et al.
Publicado: (2021) -
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets
por: Glenn A. Marsh, et al.
Publicado: (2021) -
ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7
por: Robert J. Fischer, et al.
Publicado: (2021) -
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
por: Kathryn A. Ryan, et al.
Publicado: (2021) -
Potential global impacts of alternative dosing regimen and rollout options for the ChAdOx1 nCoV-19 vaccine
por: Ricardo Aguas, et al.
Publicado: (2021)